Genaro R. Villa - Concepedia

Author

Genaro R. Villa

University of California San Diego ORCID

Also Known As

G. R. Villa, G. Villa, Genaro R Villa, Genaro R. Villa, Genaro Rodriguez Villa, Genaro Villa, Genaro R. Villa

166

Publications

Citations

H-Index

Concepts

All Affiliations

University of California San Diego Ludwig Cancer Research University of California, Los Angeles Moores Cancer Center UCLA Jonsson Comprehensive Cancer Center

About

Genaro R. Villa is an author at University of California San Diego specializing in tumor biology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	1.2K
2	Cell Biology	4	4	954
3	Biochemistry	1	1	204
4	Pathology	1	1	158
5	Pharmacology	1	1	204

Genaro R. Villa

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
mTOR Complex 2 Controls Glycolytic Metabolism in Glioblastoma through FoxO Acetylation and Upregulation of c-Myc Kenta Masui, Kazuhiro Tanaka, David Akhavan, Cell Metabolism Neuro-oncologyMedicineMtor Complex 2Foxo AcetylationCancer Biology	2013	390
Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid Remodeling Junfeng Bi, Taka-Aki Ichu, Ciro Zanca, Cell Metabolism Cancer ResearchOncogene AmplificationOncogenic AgentMedicineCell Proliferation	2019	224
mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT Yuchao Gu, Claudio P. Albuquerque, Daniel Braas, Molecular Cell BiochemistryOncogenic AgentMedicinePharmacologyCancer Cell Biology	2017	204
EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling Feng Liu, Gary C. Hon, Genaro R. Villa, Molecular Cell Neuro-oncologyGliomaCancer GenomicsTumor SuppressorRadiation Oncology	2015	182
EGFR Mutation-Induced Alternative Splicing of Max Contributes to Growth of Glycolytic Tumors in Brain Cancer Ivan Babić, Erik S. Anderson, Kazuhiro Tanaka, Cell Metabolism Neuro-oncologyGlycolytic TumorsMedicineMax ContributesPathology	2013	158
De-Repression of <i>PDGFRβ</i> Transcription Promotes Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Glioblastoma Patients David Akhavan, Alexandra L. Pourzia, Alex Nourian, Cancer Discovery	2013	139
Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance Kenta Masui, Kazuhiro Tanaka, Shiro Ikegami, Proceedings of the National Academy of Sciences	2015	118
Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity Ciro Zanca, Genaro R. Villa, Jorge A. Benítez, Genes & Development	2017	71
A Urokinase Receptor–Bim Signaling Axis Emerges during EGFR Inhibitor Resistance in Mutant EGFR Glioblastoma Jill Wykosky, Jingjing Hu, German G. Gomez, Cancer Research	2014	58
The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas Beatrice Gini, Ciro Zanca, Deliang Guo, Clinical Cancer Research	2013	48

Page 1